These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8425163)

  • 1. RDS and surfactant replacement: the double-edged sword.
    Etherington H; Lawrence J; Davis D
    Can Nurse; 1993 Jan; 89(1):14-7. PubMed ID: 8425163
    [No Abstract]   [Full Text] [Related]  

  • 2. Artificial surfactant to prevent and treat neonatal respiratory distress syndrome.
    Enhorning G
    Pediatrics; 1980 Nov; 66(5):799-800. PubMed ID: 7432889
    [No Abstract]   [Full Text] [Related]  

  • 3. Surfactant for respiratory distress syndrome.
    Bierman SF
    N Engl J Med; 1989 Sep; 321(12):834. PubMed ID: 2671737
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthetic surfactant.
    Long W
    Semin Perinatol; 1993 Aug; 17(4):275-84. PubMed ID: 8140442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer?
    Chima RS; Zingarelli B
    Crit Care Med; 2007 Oct; 35(10):2442-3. PubMed ID: 17885382
    [No Abstract]   [Full Text] [Related]  

  • 6. Does surfactant therapy prolong dying? Age at in-hospital death of extremely premature babies.
    Coulter DM; Jung AL
    J Perinatol; 1996; 16(3 Pt 1):166-70; quiz 171-2. PubMed ID: 8817423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant and the neonatal lung.
    Gibson AT
    Br J Hosp Med; 1997 Oct 15-Nov 4; 58(8):381-4, 397. PubMed ID: 9509038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome.
    Hallman M; Merritt TA; Schneider H; Epstein BL; Mannino F; Edwards DK; Gluck L
    Pediatrics; 1983 Apr; 71(4):473-82. PubMed ID: 6340042
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthetic surfactants in infants with respiratory distress syndrome.
    Perlman JM; Moya F
    N Engl J Med; 1992 Jun; 326(25):1703-4; author reply 1704-5. PubMed ID: 1588992
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
    Ghaemi S; Mohamadymasodi M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant treatment for respiratory distress syndrome following prolonged rupture of membranes.
    Tubman TR; Halliday HL
    Eur J Pediatr; 1990 Jul; 149(10):727-9. PubMed ID: 2209667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous surfactant therapy in newborns.
    Rodriguez RJ; Martin RJ
    Respir Care Clin N Am; 1999 Dec; 5(4):595-616. PubMed ID: 10565883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the treatment of the respiratory distress syndrome in premature infants with tris(hydroxymethyl)-aminomethane (THAM) and wetting agents].
    Jarre W; Ketterle W; Reinwein H
    Helv Paediatr Acta; 1965 Apr; 20(1):27-39. PubMed ID: 5828973
    [No Abstract]   [Full Text] [Related]  

  • 15. The 5 W's of surfactant for respiratory distress syndrome of the premature infant.
    Parmigiani S
    J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():25-7. PubMed ID: 15590430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifth time's the charm for infant respiratory distress drug.
    Katsnelson A
    Nat Biotechnol; 2012 May; 30(5):380. PubMed ID: 22565949
    [No Abstract]   [Full Text] [Related]  

  • 17. Surfactant replacement therapy for respiratory distress syndrome in preterm infants: United Kingdom national consensus.
    Banerjee S; Fernandez R; Fox GF; Goss KCW; Mactier H; Reynolds P; Sweet DG; Roehr CC
    Pediatr Res; 2019 Jul; 86(1):12-14. PubMed ID: 30780152
    [No Abstract]   [Full Text] [Related]  

  • 18. The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome.
    Gerstmann DR; Minton SD; Stoddard RA; Meredith KS; Monaco F; Bertrand JM; Battisti O; Langhendries JP; Francois A; Clark RH
    Pediatrics; 1996 Dec; 98(6 Pt 1):1044-57. PubMed ID: 8951252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surfactant replacement therapy in neonatal respiratory distress syndrome: prophylactic therapy versus treating of established disease].
    Lubetzky R; Dolberg S
    Harefuah; 1999 Nov; 137(10):464-7. PubMed ID: 10959346
    [No Abstract]   [Full Text] [Related]  

  • 20. Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: congratulations and corrections.
    Moya F; Sinha S; D'Agostino RB
    Pediatrics; 2008 Jun; 121(6):1290-1; author reply 1291-2. PubMed ID: 18519504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.